{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:26:38Z","timestamp":1792661198449,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ophtha.2014.10.027","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T23:01:12Z","timestamp":1421362872000},"page":"817-821","source":"Crossref","is-referenced-by-count":80,"title":["Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)"],"prefix":"10.1016","volume":"122","author":[{"given":"Travis A.","family":"Meredith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin A.","family":"McCannel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-533X","authenticated-orcid":false,"given":"Bernard H.","family":"Doft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Peskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4249-2467","authenticated-orcid":false,"given":"Maureen G.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Prenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2014.10.027_bib1","article-title":"IVT injections: Health policy implications","author":"Williams","year":"2014","journal-title":"Rev Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2014.10.027_bib3","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.10.027_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3928\/23258160-20140306-08","article-title":"Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"45","author":"Fileta","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.ophtha.2014.10.027_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: a comprehensive review","volume":"24","author":"Jager","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.10.027_bib6","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archophthalmol.2009.304","article-title":"Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials","volume":"127","author":"Bhavsar","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archophthalmol.2011.227","article-title":"Bacterial dispersal associated with speech in the setting of intravitreous injections","volume":"129","author":"Wen","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib8","first-page":"473","article-title":"Reducing oral flora contamination of intravitreal injections with face mask or silence","volume":"32","author":"Doshi","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.10.027_bib9","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archophthalmol.2011.213","article-title":"Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections","volume":"129","author":"Kim","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ophtha.2012.01.016","article-title":"Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection","volume":"119","author":"Milder","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.10.027_bib11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ophtha.2012.11.005","article-title":"Changes in ocular flora in eyes exposed to ophthalmic antibiotics","volume":"120","author":"Dave","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.10.027_bib12","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2014.10.027_bib13","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.10.027_bib14","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.ophtha.2012.06.040","article-title":"Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials","volume":"119","author":"DeCroos","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.10.027_bib15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ophtha.2014.10.027_bib16","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1097\/IAE.0b013e31820f4b4f","article-title":"Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate","volume":"31","author":"Bhatt","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.10.027_bib17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/IAE.0b013e3181633fee","article-title":"Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection","volume":"28","author":"Mason","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.10.027_bib18","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.ophtha.2007.05.062","article-title":"A\u00a0phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema","volume":"114","author":"Scott","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.10.027_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/sj.eye.6702683","article-title":"Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection","volume":"21","author":"Aggio","year":"2007","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2014.10.027_bib20","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/eye.2009.7","article-title":"Incidence and\u00a0management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection","volume":"23","author":"Artunay","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2014.10.027_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","article-title":"Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES)","volume":"246","author":"Wu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib22","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","article-title":"Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis","volume":"113","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3928\/1542-8877-20020901-06","article-title":"Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995\u20132001)","volume":"33","author":"Eifrig","year":"2002","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.ophtha.2014.10.027_bib24","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ophtha.2004.01.028","article-title":"Bleb-associated endophthalmitis: clinical characteristics and visual outcomes","volume":"111","author":"Busbee","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.10.027_bib25","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archopht.1985.01050090092039","article-title":"Chemical preparation of the eye in ophthalmic surgery IV: a comparison of povidone-iodine in conjunction with prophylactic antibiotic","volume":"103","author":"Isenberg","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/IAE.0b013e31816b3180","article-title":"Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections","volume":"28","author":"de Caro","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.10.027_bib27","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ophtha.2009.02.024","article-title":"A\u00a0prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections","volume":"116","author":"Moss","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.10.027_bib28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaophthalmol.2013.2379","article-title":"Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection","volume":"131","author":"Yin","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archophthalmol.2012.227","article-title":"Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics","volume":"130","author":"Bhavsar","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib30","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.ophtha.2012.02.014","article-title":"Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections","volume":"119","author":"Cheung","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.10.027_bib31","series-title":"ASRS 2008 Preferences and Trends Membership Survey: Chico, CA","year":"2008"},{"key":"10.1016\/j.ophtha.2014.10.027_bib32","series-title":"ASRS 2013 Preferences and Trends Membership Survey: Chicago, IL","year":"2013"},{"key":"10.1016\/j.ophtha.2014.10.027_bib33","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/bjophthalmol-2011-301439","article-title":"Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes","volume":"96","author":"Simunovic","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib34","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/IAE.0b013e31820a67e4","article-title":"Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies","volume":"31","author":"McCannel","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.10.027_bib35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0002-9394(03)00333-7","article-title":"Endophthalmitis after ganciclovir implant in patients with AIDS and cytomegalovirus retinitis","volume":"136","author":"Shane","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.10.027_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/bjo.2008.138479","article-title":"Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)","volume":"93","author":"Georgopoulos","year":"2009","journal-title":"Br J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014010446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014010446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T22:13:23Z","timestamp":1651011203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642014010446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0161642014010446"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.10.027","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}